These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis. Xiao J, Long F, Peng T, Hu LB, Cai H, Chen R, Chen WL. Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083 [Abstract] [Full Text] [Related]
5. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma]. Zhao XY, Li N, Ding HG, Jiang FF. Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806 [Abstract] [Full Text] [Related]
6. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Morota K, Nakagawa M, Sekiya R, Hemken PM, Sokoll LJ, Elliott D, Chan DW, Dowell BL. Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906 [Abstract] [Full Text] [Related]
8. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis. Zhang Y, Xi Y, Fang J, Luo S, Wilson JJ, Huang RP. J Immunoassay Immunochem; 2016 Apr; 37(4):390-406. PubMed ID: 27088654 [Abstract] [Full Text] [Related]
9. Value of Golgi protein 73 monoclonal antibody in diagnosis of hepatocellular carcinoma. Wang C, Hua-yu Y, Yi-lei M, Jin-chun Z, Hai-feng X, Gui-yong J, Yan-ling J, Xin-xin C, Xin L, Xin-ting S, Hong-bing Z. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):39-44. PubMed ID: 21375936 [Abstract] [Full Text] [Related]
10. Golgi protein 73(GP73), a useful serum marker in liver diseases. Liu X, Wan X, Li Z, Lin C, Zhan Y, Lu X. Clin Chem Lab Med; 2011 Aug; 49(8):1311-1316. PubMed ID: 21663469 [Abstract] [Full Text] [Related]
12. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma]. Zhao Y, Li Y, Hu B, He X, Huang J, Zhan M, Lu L. Zhonghua Yi Xue Za Zhi; 2014 Feb 11; 94(5):390-2. PubMed ID: 24746091 [Abstract] [Full Text] [Related]
13. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma. Jiao C, Cui L, Piao J, Qi Y, Yu Z. J Cancer Res Ther; 2018 Feb 11; 14(6):1239-1244. PubMed ID: 30488837 [Abstract] [Full Text] [Related]
14. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Hu JS, Wu DW, Liang S, Miao XY. Med Oncol; 2010 Jun 11; 27(2):339-45. PubMed ID: 19399652 [Abstract] [Full Text] [Related]
17. [Diagnostic value and clinical significance of the Golgi protein-73 in hepatocellular carcinoma]. Shi QF, Pan XD, Zhang WG, Shao WF. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec 11; 26(6):480-2. PubMed ID: 23627036 [Abstract] [Full Text] [Related]
19. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma. Shi Y, Chen J, Li L, Sun Z, Zen L, Xu S, Zhang Y, Zhang L. Technol Cancer Res Treat; 2011 Jun 11; 10(3):287-94. PubMed ID: 21517136 [Abstract] [Full Text] [Related]